The recent “final settle” for urine-based “Specimen Validity Testing” (outlined below) is clearly of limited value, being of the class who it does little to solicitation the efficacious practice of drug abusers cheatig urine tests.

Observed collection is the only method to assure specimen validity.

The ODAPC / DOT / & SAMHSA must stop their “political crumbling” to private interest groups such as large urine laboratories and take . choice specimen types - oral liquid and gaseous, hair - where observed specimen collection is the norm.

While the General Workplace can exhibit effective drug free workplace programs, those subject to Federal Mandated Drug Testing clearly can not.

Summary of Final Rule according to Specimen Validity Testing

Published in today’sitting Federal Register is a Department of Transportation Final Rule:

Procedures for Transportation Workplace Drug and Alcohol Testing Programs

In summary:

1. This Final Rule makes it mandatory for laboratories to exhibition all DOT specimens for sample validity (i.e., adulterants and urine substitutes) and for laboratories to follow all Department of Health and Human Resources (HHS) protocols for doing so.

2. Observed collections will afford less privacy in order to guard against employee use of items designed specifically to beat the testing process.

a. Directly observed collections will continue to occur barely when there is a specific reason to believe that an employee may be attempting, or hold sufficient reason, to evade the testing process.

b. Items such in the same manner with prosthetic devices designed to convey clean urine will be checked for by observers with both male animal and female donors. The keeper devise be under the necessity the employee raise and lower clothing, and then put it back into place for the observed collection.

c. Observed collections wish now be required, rather than optional, for all return-to-duty and follow-up drug testing.

3. In an effort to thwart those who would manufacturer products designed to adulterate specimens, the Final Rule will no longer have easy-to-follow tables and charts outlining the adulterants for which laboratories are testing and the philosophical cutoff levels at which laboratories are testing them.

4. Definitions in the Final Rule have been changed to harmonize with the HHS.

5. During an invalid result Medical Review Officer (MRO) review, an employee access of adulterating or substituting a specimen is now a refusal to test.

6. Pursuant to MRO requests, the Final Rule will close the potentially without end loop on invalid specimen results; and employees requiring negative results , when they regard medical reasons for providing invalid results, devise be able to get them through medical evaluations to rule out signs and symptoms of drug use.

7. The Final Rule will also streamline and simplify the potential myriad of complicated laboratory-confirmed and MRO-verified drug test results.

8. The Final Rule requires drug testing laboratories to report to DOT semi-annual statistical summaries on all of their DOT testing.

9. The Final Rule effective date is August 25, 2008.

??? ???? ??????? ?? ????????? ??????

Мой блог находят по следующим фразам